Beone Medicines Ltd
(ONC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,036,868 | 2,756,056 | 2,516,411 | 2,627,410 | 2,701,933 |
| Receivables | 863,281 | 770,776 | 717,239 | 676,278 | 569,047 |
| Inventories | 531,687 | 502,867 | 494,660 | 494,986 | 431,676 |
| TOTAL | $5,664,477 | $4,310,221 | $3,896,492 | $3,991,593 | $3,911,736 |
| Non-Current Assets | |||||
| PPE Net | 1,628,114 | 1,615,792 | 1,598,588 | 1,578,423 | 1,562,965 |
| Intangibles | 63,581 | 64,890 | 50,139 | 51,095 | 53,939 |
| Other Non-Current Assets | 276,414 | 307,491 | 296,307 | 299,799 | 302,220 |
| TOTAL | $1,968,109 | $1,988,173 | $1,945,034 | $1,929,317 | $1,919,124 |
| Total Assets | $7,632,586 | $6,298,394 | $5,841,526 | $5,920,910 | $5,830,860 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 383,676 | 360,783 | 364,498 | 404,997 | 307,532 |
| Accrued Expenses | 1,001,661 | 908,882 | 692,179 | 803,713 | 717,343 |
| Other current liabilities | 142,841 | 108,992 | 111,127 | 111,154 | 104,067 |
| TOTAL | $2,368,425 | $2,209,837 | $1,983,721 | $2,214,899 | $2,025,332 |
| Non-Current Liabilities | |||||
| Long Term Debt | 139,571 | 146,091 | 160,157 | 166,484 | 187,513 |
| Other Non-Current Liabilities | 948,198 | 127,898 | 155,025 | 165,298 | 166,007 |
| TOTAL | $1,134,835 | $318,082 | $358,292 | $373,789 | $369,455 |
| Total Liabilities | $3,503,260 | $2,527,919 | $2,342,013 | $2,588,688 | $2,394,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,658 | 110,029 | 107,947 | 106,721 | 106,618 |
| Common Shares | 144 | 143 | 140 | 138 | 138 |
| Retained earnings | -8,386,405 | -8,511,246 | -8,605,566 | -8,606,836 | -8,454,955 |
| Other shareholders' equity | -101,253 | -113,702 | -142,321 | -148,990 | -83,530 |
| TOTAL | $4,129,326 | $3,770,475 | $3,499,513 | $3,332,222 | $3,436,073 |
| Total Liabilities And Equity | $7,632,586 | $6,298,394 | $5,841,526 | $5,920,910 | $5,830,860 |